{"transactions":[{"id":4632777,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-03T00:02:39.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":203,"price":121.35,"value":24634.05,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 1,642 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":25838,"source":{"system":"sec-edgar","filing":"0001409601-26-000015","document":"wk-form4_1790971354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000140960126000015/wk-form4_1790971354.xml","form_type":"4"}},{"id":719801,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-02T20:08:07.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":252,"price":113.36,"value":28566.72,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 1,642 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":25635,"source":{"system":"sec-edgar","filing":"0001409601-26-000011","document":"wk-form4_1783022882.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000140960126000011/wk-form4_1783022882.xml","form_type":"4"}},{"id":732421,"issuer":{"id":5996,"kind":"organization","name":"Sionna Therapeutics, Inc.","symbol":"SION"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-18T21:33:10.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":17340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full upon the earlier of June 17, 2027 or the date of the next annual meeting of Sionna Therapeutics, Inc., subject to the Reporting Person's continued service on such vesting date."}],"balance_after":17340,"derivative":{"exercise_price":36.73,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":17340},"source":{"system":"sec-edgar","filing":"0001409601-26-000010","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2036042/000140960126000010/edgardoc.xml","form_type":"4"}},{"id":743872,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2026-06-10T20:07:54.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":6111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":6111,"derivative":{"exercise_price":100.64,"expiration_date":"2036-06-07","underlying":"Common Stock","underlying_shares":6111},"source":{"system":"sec-edgar","filing":"0001409601-26-000008","document":"wk-form4_1781122071.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000140960126000008/wk-form4_1781122071.xml","form_type":"4"}},{"id":743871,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T20:07:54.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":1642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 1,642 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":25383,"source":{"system":"sec-edgar","filing":"0001409601-26-000008","document":"wk-form4_1781122071.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000140960126000008/wk-form4_1781122071.xml","form_type":"4"}},{"id":768948,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-05-21T20:02:16.000Z","date":"2026-05-19","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":0,"derivative":{"exercise_price":84.53,"expiration_date":"2026-05-26","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001409601-26-000006","document":"wk-form4_1779393732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000140960126000006/wk-form4_1779393732.xml","form_type":"4"}},{"id":768947,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T20:02:16.000Z","date":"2026-05-19","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":94.93,"value":1423950.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":23741,"source":{"system":"sec-edgar","filing":"0001409601-26-000006","document":"wk-form4_1779393732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000140960126000006/wk-form4_1779393732.xml","form_type":"4"}},{"id":768946,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T20:02:16.000Z","date":"2026-05-19","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":84.53,"value":1267950.0,"ownership":{"direct":true},"balance_after":38741,"source":{"system":"sec-edgar","filing":"0001409601-26-000006","document":"wk-form4_1779393732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000140960126000006/wk-form4_1779393732.xml","form_type":"4"}},{"id":821545,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T20:09:54.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":265,"price":94.12,"value":24941.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":23741,"source":{"system":"sec-edgar","filing":"0001409601-26-000004","document":"wk-form4_1775160591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000140960126000004/wk-form4_1775160591.xml","form_type":"4"}},{"id":831135,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-23T09:18:12.000Z","date":"2026-03-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5398,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each share of Common Stock subject to vesting, repurchase or other lapse restriction and that was granted under an Issuer stock plan and outstanding as of immediately prior to the Effective Time was deemed to be fully vested and cancelled and converted into the right to receive the Merger Consideration, less any applicable tax withholding."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-118743","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000119312526118743/ownership.xml","form_type":"4"}},{"id":831134,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-23T09:18:12.000Z","date":"2026-03-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20640,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 23, 2026, pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 19, 2025, by and among Exact Sciences Corporation, a Delaware corporation (the \"Issuer\"), Abbott Laboratories, an Illinois corporation (\"Parent\"), and Badger Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent (\"Merger Sub\"), Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent. At the effective time of the Merger (the \"Effective Time\"), on the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share (\"Common Stock\"), issued and outstanding immediately prior to the Effective Time, with certain exceptions, was converted into the right to receive $105.00 in cash, without interest (the \"Merger Consideration\")."}],"balance_after":5398,"source":{"system":"sec-edgar","filing":"0001193125-26-118743","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000119312526118743/ownership.xml","form_type":"4"}},{"id":953733,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-05T21:06:21.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":241,"price":98.77,"value":23803.57,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":23476,"source":{"system":"sec-edgar","filing":"0001409601-26-000002","document":"wk-form4_1767647177.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000140960126000002/wk-form4_1767647177.xml","form_type":"4"}},{"id":1028466,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T20:09:22.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":285,"price":84.81,"value":24170.85,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":23235,"source":{"system":"sec-edgar","filing":"0001409601-25-000004","document":"wk-form4_1759435758.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000140960125000004/wk-form4_1759435758.xml","form_type":"4"}},{"id":1096676,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T20:45:50.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":361,"price":68.1,"value":24584.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":22950,"source":{"system":"sec-edgar","filing":"0000879169-25-000070","document":"wk-form4_1751489113.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916925000070/wk-form4_1751489113.xml","form_type":"4"}},{"id":1110091,"issuer":{"id":5996,"kind":"organization","name":"Sionna Therapeutics, Inc.","symbol":"SION"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-16T21:06:56.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":19959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full upon the earlier of June 12, 2026 or the date of the next annual meeting of Sionna Therapeutics, Inc., subject to the Reporting Person's continued service on such vesting date."}],"balance_after":19959,"derivative":{"exercise_price":16.99,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":19959},"source":{"system":"sec-edgar","filing":"0002036042-25-000028","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2036042/000203604225000028/edgardoc.xml","form_type":"4"}},{"id":1110219,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T17:30:19.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":5398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy."}],"balance_after":26038,"source":{"system":"sec-edgar","filing":"0000950170-25-086889","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000095017025086889/ownership.xml","form_type":"4"}},{"id":1113183,"issuer":{"id":7122,"kind":"organization","name":"Xilio Therapeutics, Inc."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:36:08.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 11, 2025 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 11, 2026 and (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":31000,"derivative":{"exercise_price":0.693,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001415889-25-016968","document":"form4-06122025_080604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409601/000141588925016968/form4-06122025_080604.xml","form_type":"4"}},{"id":1114186,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2025-06-12T20:29:06.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":9216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":9216,"derivative":{"exercise_price":70.07,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":9216},"source":{"system":"sec-edgar","filing":"0001628280-25-031006","document":"wk-form4_1749760138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000162828025031006/wk-form4_1749760138.xml","form_type":"4"}},{"id":1114185,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:29:06.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":2518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":22589,"source":{"system":"sec-edgar","filing":"0001628280-25-031006","document":"wk-form4_1749760138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000162828025031006/wk-form4_1749760138.xml","form_type":"4"}},{"id":1185026,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T20:06:28.000Z","date":"2025-03-31","kind":"grant","planned":true,"acquired":true,"shares":358,"price":60.55,"value":21676.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,830 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":20071,"source":{"system":"sec-edgar","filing":"0001628280-25-016172","document":"wk-form4_1743624374.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000162828025016172/wk-form4_1743624374.xml","form_type":"4"}},{"id":1317107,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T18:06:45.000Z","date":"2024-12-31","kind":"grant","planned":true,"acquired":true,"shares":331,"price":69.07,"value":22862.17,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,830 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":19713,"source":{"system":"sec-edgar","filing":"0000879169-25-000004","document":"wk-form4_1735927599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916925000004/wk-form4_1735927599.xml","form_type":"4"}},{"id":1324487,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-20T16:30:08.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":5939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 17, 2024, the Reporting Person filed a Form 4 which, due to an administrative error, incorrectly reported that the Reporting person had been awarded 5,444 shares of restricted stock pursuant to the Company's non-employee director compensation policy. This amendment to Form 4 is being filed to reflect the correct amount of shares awarded pursuant to the policy."}],"balance_after":20640,"source":{"system":"sec-edgar","filing":"0000950170-24-139097","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000095017024139097/ownership.xml","form_type":"4/A","original_submission_date":"2024-06-17"}},{"id":1395588,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T17:01:26.000Z","date":"2024-09-30","kind":"grant","planned":true,"acquired":true,"shares":368,"price":66.1,"value":24324.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,830 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":19382,"source":{"system":"sec-edgar","filing":"0000879169-24-000159","document":"wk-form4_1727888479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000159/wk-form4_1727888479.xml","form_type":"4"}},{"id":1464335,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T17:22:37.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":399,"price":60.62,"value":24187.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,830 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":19014,"source":{"system":"sec-edgar","filing":"0000879169-24-000102","document":"wk-form4_1719940951.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000102/wk-form4_1719940951.xml","form_type":"4"}},{"id":1477165,"issuer":{"id":7122,"kind":"organization","name":"Xilio Therapeutics, Inc."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-17T20:30:09.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 14, 2024 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 14, 2025 and (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.02,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-24-017205","document":"form4-06172024_040604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409601/000141588924017205/form4-06172024_040604.xml","form_type":"4"}},{"id":1477713,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-17T17:30:11.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":5444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy."}],"balance_after":20145,"source":{"system":"sec-edgar","filing":"0000950170-24-074413","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000095017024074413/ownership.xml","form_type":"4"}},{"id":1479841,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2024-06-14T16:13:17.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":12517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":12517,"derivative":{"exercise_price":59.94,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":12517},"source":{"system":"sec-edgar","filing":"0000879169-24-000091","document":"wk-form4_1718381589.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000091/wk-form4_1718381589.xml","form_type":"4"}},{"id":1479840,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T16:13:17.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":2830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 2,830 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":18615,"source":{"system":"sec-edgar","filing":"0000879169-24-000091","document":"wk-form4_1718381589.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000091/wk-form4_1718381589.xml","form_type":"4"}},{"id":1555007,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T16:12:40.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":403,"price":56.97,"value":22958.91,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,505 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":15785,"source":{"system":"sec-edgar","filing":"0000879169-24-000070","document":"wk-form4_1712074352.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000070/wk-form4_1712074352.xml","form_type":"4"}},{"id":1694820,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-03T17:08:16.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":412,"price":62.79,"value":25869.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,505 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":15382,"source":{"system":"sec-edgar","filing":"0000879169-24-000004","document":"wk-form4_1704301688.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000004/wk-form4_1704301688.xml","form_type":"4"}},{"id":1769021,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-03T20:02:56.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":379,"price":57.77,"value":21894.83,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,505 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":14970,"source":{"system":"sec-edgar","filing":"0000879169-23-000030","document":"wk-form4_1696363357.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916923000030/wk-form4_1696363357.xml","form_type":"4"}},{"id":1838134,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-05T20:00:45.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":380,"price":62.25,"value":23655.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,505 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":14591,"source":{"system":"sec-edgar","filing":"0001209191-23-040943","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123040943/doc4.xml","form_type":"4"}},{"id":1853303,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-06-16T20:00:20.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":11294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":11294,"derivative":{"exercise_price":61.44,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":11294},"source":{"system":"sec-edgar","filing":"0001209191-23-037795","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123037795/doc4.xml","form_type":"4"}},{"id":1853302,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:00:20.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":2505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan).  The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":14211,"source":{"system":"sec-edgar","filing":"0001209191-23-037795","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123037795/doc4.xml","form_type":"4"}},{"id":1857116,"issuer":{"id":7122,"kind":"organization","name":"Xilio Therapeutics, Inc."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-13T20:30:22.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":13200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 12, 2023 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 12, 2024 and (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":13200,"derivative":{"exercise_price":2.8,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":13200},"source":{"system":"sec-edgar","filing":"0001415889-23-009738","document":"form4-06132023_040612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409601/000141588923009738/form4-06132023_040612.xml","form_type":"4"}},{"id":1859271,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-12T16:30:52.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":3599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy."}],"balance_after":14701,"source":{"system":"sec-edgar","filing":"0001209191-23-036331","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919123036331/doc4.xml","form_type":"4"}},{"id":1930414,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T20:00:27.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":318,"price":72.27,"value":22981.86,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,144 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":11706,"source":{"system":"sec-edgar","filing":"0001209191-23-022633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123022633/doc4.xml","form_type":"4"}},{"id":2070431,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T21:02:25.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":294,"price":80.32,"value":23614.08,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,144 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":11388,"source":{"system":"sec-edgar","filing":"0001209191-23-000806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123000806/doc4.xml","form_type":"4"}},{"id":2146046,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T20:00:40.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":339,"price":66.64,"value":22590.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,144 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":11094,"source":{"system":"sec-edgar","filing":"0001209191-22-052162","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122052162/doc4.xml","form_type":"4"}},{"id":2218015,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-01T20:01:24.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":321,"price":75.97,"value":24386.37,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,144 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":10755,"source":{"system":"sec-edgar","filing":"0001209191-22-040183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122040183/doc4.xml","form_type":"4"}},{"id":2222981,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2022-06-23T20:09:40.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":29307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 21, 2022. The shares underlying this option vest as to 100% of the underlying shares on June 21, 2023."}],"balance_after":29307,"derivative":{"exercise_price":18.09,"expiration_date":"2032-06-21","underlying":"Common stock","underlying_shares":29307},"source":{"system":"sec-edgar","filing":"0001439222-22-000061","document":"wf-form4_165601496361572.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000061/wf-form4_165601496361572.xml","form_type":"4"}},{"id":2222980,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock unit","published_at":"2022-06-23T20:09:40.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":4975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 21, 2022. The shares underlying the stock units will vest in full on June 21, 2023. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 21, 2022. The shares underlying the stock units will vest in full on June 21, 2023. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":4975,"derivative":{"underlying":"Common stock","underlying_shares":4975},"source":{"system":"sec-edgar","filing":"0001439222-22-000061","document":"wf-form4_165601496361572.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000061/wf-form4_165601496361572.xml","form_type":"4"}},{"id":2227473,"issuer":{"id":7122,"kind":"organization","name":"Xilio Therapeutics, Inc."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T20:30:33.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":13200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was granted on June 15, 2022 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 15, 2023 and (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a director of the Issuer through the vesting date."}],"balance_after":13200,"derivative":{"exercise_price":2.28,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":13200},"source":{"system":"sec-edgar","filing":"0001415889-22-006744","document":"form4-06172022_040611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409601/000141588922006744/form4-06172022_040611.xml","form_type":"4"}},{"id":2228902,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-17T20:01:04.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":9124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":9124,"derivative":{"exercise_price":68.55,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":9124},"source":{"system":"sec-edgar","filing":"0001209191-22-037801","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122037801/doc4.xml","form_type":"4"}},{"id":2228901,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T20:01:04.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":2144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan).  The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":10434,"source":{"system":"sec-edgar","filing":"0001209191-22-037801","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122037801/doc4.xml","form_type":"4"}},{"id":2234522,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T17:25:43.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":5606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy."}],"balance_after":11102,"source":{"system":"sec-edgar","filing":"0001209191-22-036409","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919122036409/doc4.xml","form_type":"4"}},{"id":2258117,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock unit","published_at":"2022-05-24T20:13:06.000Z","date":"2022-05-20","kind":"exercise","acquired":false,"shares":1585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":1585},"source":{"system":"sec-edgar","filing":"0001439222-22-000054","document":"wf-form4_165342316015735.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000054/wf-form4_165342316015735.xml","form_type":"4"}},{"id":2258116,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-05-24T20:13:06.000Z","date":"2022-05-20","kind":"exercise","acquired":true,"shares":1585,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6549,"source":{"system":"sec-edgar","filing":"0001439222-22-000054","document":"wf-form4_165342316015735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000054/wf-form4_165342316015735.xml","form_type":"4"}},{"id":2309730,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T20:00:16.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":326,"price":79.42,"value":25890.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":8290,"source":{"system":"sec-edgar","filing":"0001209191-22-022282","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122022282/doc4.xml","form_type":"4"}},{"id":2451963,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T21:14:08.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":343,"price":73.4,"value":25176.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":7964,"source":{"system":"sec-edgar","filing":"0001209191-22-000690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122000690/doc4.xml","form_type":"4"}},{"id":2534491,"issuer":{"id":7122,"kind":"organization","name":"Xilio Therapeutics, Inc."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-10-26T21:01:05.000Z","date":"2021-10-26","kind":"grant","acquired":true,"shares":65528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 11, 2021, the reporting person was granted an option to purchase 65,528 shares of common stock of the Company, the vesting of which was contingent upon the closing of the Company's IPO. The Company's IPO closed as of October 26, 2021. On October 26, 2021, 20,477 shares underlying the option vested and the remainder will vest in equal monthly installments until July 16, 2024."}],"balance_after":65528,"derivative":{"exercise_price":5.89,"expiration_date":"2021-03-10","underlying":"Common Stock","underlying_shares":65528},"source":{"system":"sec-edgar","filing":"0001104659-21-130022","document":"tm2130646-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1409601/000110465921130022/tm2130646-19_4seq1.xml","form_type":"4"}},{"id":2534490,"issuer":{"id":7122,"kind":"organization","name":"Xilio Therapeutics, Inc."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-10-26T21:01:05.000Z","date":"2021-10-26","kind":"grant","acquired":true,"shares":44033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 23, 2020, the reporting person was granted an option to purchase 44,033 shares of common stock of the Company, the vesting of which was contingent upon the closing of the Company's initial public offering (\"IPO\"). The Company's IPO closed as of October 26, 2021. On October 26, 2021, 13,760 shares underlying the award vested and the remainder will vest in equal monthly installments until July 16, 2024."}],"balance_after":44033,"derivative":{"exercise_price":5.51,"expiration_date":"2030-07-22","underlying":"Common Stock","underlying_shares":44033},"source":{"system":"sec-edgar","filing":"0001104659-21-130022","document":"tm2130646-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409601/000110465921130022/tm2130646-19_4seq1.xml","form_type":"4"}},{"id":2553175,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T20:26:03.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":321,"price":68.78,"value":22078.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":7621,"source":{"system":"sec-edgar","filing":"0001209191-21-058958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121058958/doc4.xml","form_type":"4"}},{"id":2645466,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T16:06:34.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":2567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy."}],"balance_after":5496,"source":{"system":"sec-edgar","filing":"0001209191-21-044894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919121044894/doc4.xml","form_type":"4"}},{"id":2646193,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T11:16:16.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":283,"price":84.13,"value":23808.79,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":7300,"source":{"system":"sec-edgar","filing":"0001209191-21-044642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121044642/doc4.xml","form_type":"4"}},{"id":2686292,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2021-06-02T20:07:55.000Z","date":"2021-05-28","kind":"exercise","acquired":false,"shares":1686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":1686},"source":{"system":"sec-edgar","filing":"0001439222-21-000052","document":"wf-form4_162266445283384.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000052/wf-form4_162266445283384.xml","form_type":"4"}},{"id":2686291,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2021-06-02T20:07:55.000Z","date":"2021-05-28","kind":"exercise","acquired":true,"shares":1686,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4964,"source":{"system":"sec-edgar","filing":"0001439222-21-000052","document":"wf-form4_162266445283384.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000052/wf-form4_162266445283384.xml","form_type":"4"}},{"id":2692170,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-05-28T11:01:52.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":8010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":8010,"derivative":{"exercise_price":83.16,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":8010},"source":{"system":"sec-edgar","filing":"0001209191-21-036401","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121036401/doc4.xml","form_type":"4"}},{"id":2692169,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T11:01:52.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":1923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan).  The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":7017,"source":{"system":"sec-edgar","filing":"0001209191-21-036401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121036401/doc4.xml","form_type":"4"}},{"id":2698751,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2021-05-24T20:44:23.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":8888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on May 20, 2021. The shares underlying this option vest as to 100% of the underlying shares on May 20, 2022."}],"balance_after":8888,"derivative":{"exercise_price":56.76,"expiration_date":"2031-05-20","underlying":"Common stock","underlying_shares":8888},"source":{"system":"sec-edgar","filing":"0001439222-21-000043","document":"wf-form4_162188904410902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000043/wf-form4_162188904410902.xml","form_type":"4"}},{"id":2698750,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock unit","published_at":"2021-05-24T20:44:23.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":1585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested"}],"balance_after":1585,"derivative":{"underlying":"Common stock","underlying_shares":1585},"source":{"system":"sec-edgar","filing":"0001439222-21-000043","document":"wf-form4_162188904410902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000043/wf-form4_162188904410902.xml","form_type":"4"}},{"id":2765261,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-01T21:07:03.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":298,"price":81.27,"value":24218.46,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":5094,"source":{"system":"sec-edgar","filing":"0001209191-21-024152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121024152/doc4.xml","form_type":"4"}},{"id":2777853,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-19T17:05:52.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":2929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy and vest in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":2929,"source":{"system":"sec-edgar","filing":"0001209191-21-022123","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919121022123/doc4.xml","form_type":"4"}},{"id":2923333,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T21:55:28.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":281,"price":86.98,"value":24441.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":4796,"source":{"system":"sec-edgar","filing":"0001209191-21-001226","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121001226/doc4.xml","form_type":"4"}},{"id":3019185,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T20:43:05.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":260,"price":89.74,"value":23332.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":4515,"source":{"system":"sec-edgar","filing":"0001209191-20-052629","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120052629/doc4.xml","form_type":"4"}},{"id":3095793,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-01T20:51:31.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":229,"price":103.97,"value":23809.13,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":4255,"source":{"system":"sec-edgar","filing":"0001209191-20-039772","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120039772/doc4.xml","form_type":"4"}},{"id":3128961,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2020-06-01T21:14:00.000Z","date":"2020-05-29","kind":"exercise","acquired":false,"shares":1878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":1878},"source":{"system":"sec-edgar","filing":"0001439222-20-000053","document":"wf-form4_159104602309461.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000053/wf-form4_159104602309461.xml","form_type":"4"}},{"id":3128960,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2020-06-01T21:14:00.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":1686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested."}],"balance_after":1686,"derivative":{"underlying":"Common stock","underlying_shares":1686},"source":{"system":"sec-edgar","filing":"0001439222-20-000053","document":"wf-form4_159104602309461.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000053/wf-form4_159104602309461.xml","form_type":"4"}},{"id":3128959,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2020-06-01T21:14:00.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":8096,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 28, 2020. This option vests as to 100% of the underlying shares on May 28, 2021."}],"balance_after":8096,"derivative":{"exercise_price":53.35,"expiration_date":"2030-05-28","underlying":"Common stock","underlying_shares":8096},"source":{"system":"sec-edgar","filing":"0001439222-20-000053","document":"wf-form4_159104602309461.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000053/wf-form4_159104602309461.xml","form_type":"4"}},{"id":3128958,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-06-01T21:14:00.000Z","date":"2020-05-29","kind":"exercise","acquired":true,"shares":1878,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."}],"balance_after":3278,"source":{"system":"sec-edgar","filing":"0001439222-20-000053","document":"wf-form4_159104602309461.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000053/wf-form4_159104602309461.xml","form_type":"4"}},{"id":3132796,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-28T20:13:20.000Z","date":"2020-05-26","kind":"grant","acquired":true,"shares":10514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":10514,"derivative":{"exercise_price":98.68,"expiration_date":"2030-05-25","underlying":"Common Stock","underlying_shares":10514},"source":{"system":"sec-edgar","filing":"0001209191-20-032579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120032579/doc4.xml","form_type":"4"}},{"id":3132795,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-28T20:13:20.000Z","date":"2020-05-26","kind":"grant","acquired":true,"shares":1282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan).  The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":4026,"source":{"system":"sec-edgar","filing":"0001209191-20-032579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120032579/doc4.xml","form_type":"4"}},{"id":3187729,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-02T21:04:11.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":287,"price":73.23,"value":21017.01,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,520 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":2744,"source":{"system":"sec-edgar","filing":"0001209191-20-022680","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120022680/doc4.xml","form_type":"4"}},{"id":3324934,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T21:09:29.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":231,"price":87.32,"value":20170.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,520 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":2457,"source":{"system":"sec-edgar","filing":"0001209191-20-000810","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120000810/doc4.xml","form_type":"4"}},{"id":3401876,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T20:08:51.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":266,"price":74.23,"value":19745.18,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,520 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":2226,"source":{"system":"sec-edgar","filing":"0001209191-19-051625","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119051625/doc4.xml","form_type":"4"}},{"id":3462095,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-07-15T17:01:00.000Z","date":"2019-07-11","kind":"tax_withholding","acquired":false,"shares":5230,"price":124.2,"value":649566.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":90447,"source":{"system":"sec-edgar","filing":"0000899866-19-000080","document":"wf-form4_156322444530801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000080/wf-form4_156322444530801.xml","form_type":"4"}},{"id":3472909,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-02T20:31:18.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":237,"price":84.96,"value":20135.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,520 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001209191-19-040306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119040306/doc4.xml","form_type":"4"}},{"id":3506267,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2019-05-31T20:03:49.000Z","date":"2019-05-31","kind":"exercise","acquired":false,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on May 31, 2018. The shares underlying the stock units vested in full on May 31, 2019. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on May 31, 2018. The shares underlying the stock units vested in full on May 31, 2019. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001209191-19-033614","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919119033614/doc4.xml","form_type":"4"}},{"id":3506266,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2019-05-31T20:03:49.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":1878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":1878,"derivative":{"underlying":"Common stock","underlying_shares":1878},"source":{"system":"sec-edgar","filing":"0001209191-19-033614","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919119033614/doc4.xml","form_type":"4"}},{"id":3506265,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-05-31T20:03:49.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":8919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 29, 2019. The shares underlying this option vest as to 100% of the underlying shares on May 29, 2020."}],"balance_after":8919,"derivative":{"exercise_price":47.91,"expiration_date":"2029-05-29","underlying":"Common stock","underlying_shares":8919},"source":{"system":"sec-edgar","filing":"0001209191-19-033614","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919119033614/doc4.xml","form_type":"4"}},{"id":3506264,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2019-05-31T20:03:49.000Z","date":"2019-05-31","kind":"exercise","acquired":true,"shares":1400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."}],"balance_after":1400,"source":{"system":"sec-edgar","filing":"0001209191-19-033614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919119033614/doc4.xml","form_type":"4"}},{"id":3546951,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-29T21:04:26.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":12472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":12472,"derivative":{"exercise_price":75.03,"expiration_date":"2029-04-25","underlying":"Common Stock","underlying_shares":12472},"source":{"system":"sec-edgar","filing":"0001209191-19-026434","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119026434/doc4.xml","form_type":"4"}},{"id":3546950,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-29T21:04:26.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":1520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan).  The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":1723,"source":{"system":"sec-edgar","filing":"0001209191-19-026434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119026434/doc4.xml","form_type":"4"}},{"id":3570327,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T21:08:42.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":203,"price":86.01,"value":17460.03,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."}],"balance_after":203,"source":{"system":"sec-edgar","filing":"0001209191-19-022646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119022646/doc4.xml","form_type":"4"}},{"id":3615631,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-03-05T20:13:27.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":9428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":95677,"source":{"system":"sec-edgar","filing":"0000899866-19-000045","document":"wf-form4_155183479037689.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000045/wf-form4_155183479037689.xml","form_type":"4"}},{"id":3620729,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-03-04T17:37:57.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":1079,"price":132.93,"value":143431.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $132.90- $135.01.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":86249,"source":{"system":"sec-edgar","filing":"0000899866-19-000038","document":"wf-form4_155173906391052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000038/wf-form4_155173906391052.xml","form_type":"4"}},{"id":3666575,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-02-11T18:21:45.000Z","date":"2019-02-07","kind":"tax_withholding","acquired":false,"shares":5981,"price":119.57,"value":715148.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $119.45 - $119.57.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":87328,"source":{"system":"sec-edgar","filing":"0000899866-19-000013","document":"wf-form4_154992729099866.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000013/wf-form4_154992729099866.xml","form_type":"4"}},{"id":3868934,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-07-12T17:23:37.000Z","date":"2018-07-10","kind":"sale","acquired":false,"shares":5241,"price":131.11,"value":687147.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":93309,"source":{"system":"sec-edgar","filing":"0000899866-18-000114","document":"wf-form4_153143060154063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000114/wf-form4_153143060154063.xml","form_type":"4"}},{"id":3908238,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2018-06-04T20:10:10.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on May 31, 2018. The shares underlying the stock units will vest in full on May 31, 2019. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on May 31, 2018. The shares underlying the stock units will vest in full on May 31, 2019. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":1400,"derivative":{"underlying":"Common stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001209191-18-035022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919118035022/doc4.xml","form_type":"4"}},{"id":3908237,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-06-04T20:10:10.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 31, 2018. The shares underlying this option vest as to 100% of the underlying shares on May 31, 2019."}],"balance_after":5700,"derivative":{"exercise_price":93.5,"expiration_date":"2028-05-30","underlying":"Common stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-18-035022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919118035022/doc4.xml","form_type":"4"}},{"id":3948584,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2018-05-03T21:24:35.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in option plan)."}],"balance_after":15000,"derivative":{"exercise_price":60.85,"exercise_date":"2019-05-01","expiration_date":"2028-04-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-027732","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919118027732/doc4.xml","form_type":"4"}},{"id":4021791,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-03-02T17:02:45.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":9536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":98550,"source":{"system":"sec-edgar","filing":"0000899866-18-000064","document":"wf-form4_152002814448586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000064/wf-form4_152002814448586.xml","form_type":"4"}},{"id":4071051,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-02-08T19:17:15.000Z","date":"2018-02-08","kind":"sale","acquired":false,"shares":6079,"price":116.31,"value":707048.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $116.00 - $116.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":89014,"source":{"system":"sec-edgar","filing":"0000899866-18-000040","document":"wf-form4_151813542168787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000040/wf-form4_151813542168787.xml","form_type":"4"}},{"id":4071050,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-02-08T19:17:15.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":48228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 6, 2018, the Leadership and Compensation Committee determined that the reporting person earned 48,228 Performance Share Units upon achievement of certain performance targets previously established by the Committee. 1/3 of such shares vested on February 6, 2018 and 1/3 vest on each subsequent anniversary."}],"balance_after":95093,"source":{"system":"sec-edgar","filing":"0000899866-18-000040","document":"wf-form4_151813542168787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000040/wf-form4_151813542168787.xml","form_type":"4"}},{"id":4258642,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2017-07-12T18:11:29.000Z","date":"2017-07-10","kind":"grant","acquired":true,"shares":29089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Award of Stock Options under 2017 Incentive Plan. 25% vest on the one year anniversary of the grant date and 1/16th every 90 days thereafter."}],"balance_after":29089,"derivative":{"exercise_price":123.76,"exercise_date":"2018-07-10","expiration_date":"2027-07-10","underlying":"Common Stock, par value $.0001 per share","underlying_shares":29089},"source":{"system":"sec-edgar","filing":"0000899866-17-000149","document":"wf-form4_149989747544708.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000149/wf-form4_149989747544708.xml","form_type":"4"}},{"id":4258641,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-07-12T18:11:29.000Z","date":"2017-07-10","kind":"grant","acquired":true,"shares":46865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under 2017 Incentive Plan.  25% vest on each anniversary of the grant date."}],"balance_after":46865,"source":{"system":"sec-edgar","filing":"0000899866-17-000149","document":"wf-form4_149989747544708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000149/wf-form4_149989747544708.xml","form_type":"4"}},{"id":4280649,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-06-15T21:03:27.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 13, 2017. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2018."}],"balance_after":9000,"derivative":{"exercise_price":50.73,"expiration_date":"2027-06-12","underlying":"Common stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-17-040188","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117040188/doc4.xml","form_type":"4"}},{"id":4300471,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2017-05-31T20:26:06.000Z","date":"2017-05-26","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in option plan)."}],"balance_after":15000,"derivative":{"exercise_price":134.38,"exercise_date":"2018-05-26","expiration_date":"2027-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-036443","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919117036443/doc4.xml","form_type":"4"}},{"id":4343866,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"officer":true,"officer_title":"Executive VP and CFO"}}],"security":"Common Stock","published_at":"2017-04-27T20:23:52.000Z","date":"2017-04-25","kind":"sale","acquired":false,"shares":9892,"price":290,"value":2868680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":10813,"source":{"system":"sec-edgar","filing":"0001127602-17-015712","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217015712/form4.xml","form_type":"4"}},{"id":4387313,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":33396,"kind":"person","name":"Clancy Paul J","position":1,"cik":"0001409601","reported_name":"Clancy Paul J","relationship":{"officer":true,"officer_title":"Executive VP and CFO"}}],"security":"Common Stock","published_at":"2017-03-14T23:32:15.000Z","date":"2017-03-13","kind":"sale","acquired":false,"shares":9891,"price":291.55,"value":2883721.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":20705,"source":{"system":"sec-edgar","filing":"0001127602-17-011701","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217011701/form4.xml","form_type":"4"}}],"next_cursor":"2017-03-14T23:32:15.000000Z,4387313"}